The European Committee for Treatment and Research in Multiple Sclerosis

The ECTRIMS Podcast

Science EN ↓ 93 episodes

The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.

Be sure to visit the podcast's website and support the creator: www.ectrims.eu

Author

The European Committee for Treatment and Research in Multiple Sclerosis

Category

Science

Podcast website

www.ectrims.eu

Latest episode

Nov 4, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

How well are we measuring cognition in MS? 08.12.2025

Cognitive change is one of the most common—and most misunderstood—symptoms of multiple sclerosis. In this episode, host Brett Drummond speaks with Dr. Vicki Levitt (Columbia University) and Dr. Tom Fuchs (MS Center Amsterdam) about the state of cognition research, why measurement still lags behind clinical need, and how new tools may change the field forever.

MS Nursing: Listening, Leadership, and the Role of AI in Patient Care 13.11.2025

At every stage of the MS journey, nurses are the steady link between patients, families, and the healthcare team. In this episode, host  Brett Drummond speaks with Amy Perrin Ross , MS Specialist Nurse and Program Coordinator at Loyola University Chicago (USA) , and  Miguel Ángel Cortés-Vicente , Multiple Sclerosis Consultant Nurse at CEMCAT – Centre d'Esclerosi Múltiple de Catalunya (Spain) , abo...

Why We Need to Talk More About Mental Health in MS 29.10.2025

While much of MS care focuses on physical symptoms, mental health challenges—like depression, anxiety, loneliness, and stigma—often go under-recognised. In this episode, host Brett Drummond speaks with Dr. Rebecca MaGuire , psychologist and MS researcher at Maynooth University, who also lives with MS herself. Together they discuss why mental health must become a core part of MS care, what the late...

Patient Community Day 2025 15.10.2025

Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancing effective treatments. After the event wrapped up in Barcelona, host Brett Drummond caught up with Julie Petrin, Director of Impact and Evaluation at MS Canada and a person living with MS, and Non He...

Positive Remyelination Trial Results: Late Breaking at ECTRIMS 2025 02.10.2025

At the late breaking abstracts session at ECTRIMS 2025 in Barcelona, the CCMR-Two trial revealed promising results for myelin repair in MS using the diabetes drug metformin and the antihistamine clemastine. Straight from his presentation, trial lead Dr. Nick Cunniffe of the University of Cambridge sat down with host Brett Drummond of MStranslate to discuss the full results of CCMR-Two, our current...

Final Day Highlights of ECTRIMS 2025 26.09.2025

On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.

Day 2 Highlights of ECTRIMS 2025 25.09.2025

Dr. Barry Singer, Director and Founder of The MS Center for Innovations in Care, joins host Brett Drummond to discuss the key takeaways unveiled on the second day of ECTRIMS 2025 in Barcelona.

Day 1 Highlights of ECTRIMS 2025 24.09.2025

The 41st Congress of ECTRIMS opened in Barcelona with Professor Maria Pia Amato of the University of Florence delivering the ECTRIMS Lecture. In this conversation with host Brett Drummond, she highlights the key takeaways from Day One of ECTRIMS 2025 and shares insights on cognition and what's shaping the future of multiple sclerosis research and care.

Pre-Day Highlights of ECTRIMS 2025 23.09.2025

Direct from Barcelona, listen to Alvaro Cobo Calvo from the Multiple Sclerosis Center of Catalonia (Cemcat) and host Brett Drummond discuss the highlights of ECTRIMS 2025 Pre-Day, which is focused on specialised topics in MS and related neuroinflammatory autoimmune diseases such as MOGAD and NMOSD.

2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know 19.09.2025

The 2024 Revisions of the McDonald Diagnostic Criteria for MS have been published in The Lancet Neurology . What do these changes mean for clinical practice? In this episode, we are joined by two authors of the paper: Prof. Xavier Montalban, Chair of the International Advisory Committee on Clinical Trials in MS (IACCTMS), and Dr. Jiwon Oh of the University of Toronto. Together with host Brett Drum...

Genetics and MS: Recent Discoveries and Future Directions 08.09.2025

Genetics not only influence the risk of developing multiple sclerosis (MS), but also affect how the disease progresses and how patients respond to different treatments. Professor Philip De Jager, Chief of Neuroimmunology at Columbia University Irving Medical Center joins host Brett Drummond of MStranslate to discuss recent discoveries in MS genetics. They explore what these findings mean for patie...

The Expanding Role of Patient-Reported Outcomes in MS Research 17.07.2025

Patient-reported outcomes (PROs) have become a critical tool for capturing the lived experience of multiple sclerosis (MS), offering a perspective that extends beyond traditional clinical and imaging metrics. As research increasingly prioritises real-world relevance and individualised care, PROs provide valuable insights into symptoms such as fatigue, mood changes, and cognitive decline—factors th...

Biomarkers in MS 12.06.2025

Biomarkers are one of the most exciting and fast-evolving areas in multiple sclerosis research, offering promise for earlier diagnosis, accurate prognosis, and truly personalised treatment. Yet despite their potential, there is still significant debate that limits their widespread application in clinical and research settings. In this episode, host Brett Drummond is joined by two leading voices in...

BTK Inhibitors: The Tolebrutinib Trial Results 21.05.2025

Over the past few years, the MS research community has been following developments in a new class of therapies called Bruton's tyrosine kinase inhibitors (BTKis). At ECTRIMS 2024, the results of two tolebrutinib trials were presented as late-breaking abstracts by Dr. Robert Fox, Neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic in the US, and Dr. Jiwon Oh, Neurologist at...

The Role of Diet in Managing MS 24.04.2025

What do the latest research findings tell us about the role diet can play in the management of multiple sclerosis (MS)? How should neurologists talk about diet with their patients? While people living with MS may view their food choices as a way to exert some control over the disease, the concept of an "ideal diet" remains hotly contested. Dr. Brigit de Jong, Neurologist at MS Center Amsterdam, in...

Autologous Haematopoietic Stem Cell Transplantation for MS 27.03.2025

Autologous haematopoietic  stem cell transplantation (AHSCT) has gained considerable attention in recent years as a treatment option for multiple sclerosis (MS). As long-term clinical trial data on AHSCT continues to grow, there is increasing debate about where it fits in the current MS therapeutic landscape. Dr. Joachim Burman, Neurologist and Associate Professor at Uppsala University in Sweden,...

How Real-World Data Is Shaping MS Treatment 20.02.2025

The rise of multiple sclerosis (MS) registries worldwide has transformed MS research, providing access to vast clinical data spanning years. This development also triggers critical conversations about how best to use real-world data to answer questions over the treatment of people with MS and the potential shift towards personalised medicine. In this episode, guests Professor Tomas Kalincik, Head...

Fatigue in Multiple Sclerosis 16.01.2025

Fatigue is a common symptom of multiple sclerosis, significantly impacting the quality of life of people living with the disease. In this episode, Dr. Anne-Laure Dubessy of Hôpital Pitié-Salpêtrière in Paris and Professor Iris-Katharina Penner of the University Hospital of Bern in Switzerland join host Brett Drummond of MSTranslate to discuss the causes of MS-related fatigue, strategies for managi...

Advancing MS Knowledge through the ECTRIMS Fellowship 23.12.2024

The recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTra...

Addressing Diversity in MS Research and Care 12.12.2024

Nearly three million people worldwide are living with multiple sclerosis (MS), affecting individuals from diverse geographical, ethnic, racial, and socio-economic backgrounds. This diversity raises important questions about how these factors may influence the experiences and outcomes of those with MS, as well as whether research studies and clinical trials have sufficiently addressed this variabil...

Paediatric Multiple Sclerosis 27.11.2024

While paediatric onset multiple sclerosis is relatively rare, it presents unique challenges. Extensive research efforts are taking place around the world to better understand the disease mechanism of paediatric MS and the similarities and differences that exist with adult onset MS to help determine the best treatment options for children and adolescents. In this episode, host Brett Drummond of MST...

MS Prodrome: Implications and Future Research Directions 07.11.2024

If you talk to someone living with MS about their journey, one of the first things they will tell you is that they knew something was wrong long before they received their diagnosis. While this anecdotal evidence has been commonly discussed, it was only relatively recently that the research world has started to investigate this concept. Through this work, the idea of an MS prodrome has been studie...

Episode 37: Future MS Therapeutics 24.10.2024

Significant progress has been made in multiple sclerosis (MS) treatments over the past 20 years. What does the next 20 years hold for MS therapies? What novel targets are being investigated? What clinical trials are in the pipeline and when can we expect new medications in the market? Host Brett Drummond of MS Translate explores these questions and more with Prof. Heinz Wiendl of University of Fre...

MS Nurses at ECTRIMS 2024 10.10.2024

Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively support patients. In this episode, host Brett Drummond of MSTranslate talks with veteran MS nurses K-J Lazarus of Austin Health in Australia and Fiona d'Young of the Auckland Hospital in New Zealand.

Patient Community Day Highlights of ECTRIMS 2024: Part II 09.10.2024

The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with...

Listen to the The ECTRIMS Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.